Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.350
-0.010 (-0.74%)
Oct 3, 2025, 2:54 PM EDT - Market open
Canopy Growth Revenue
Canopy Growth had revenue of 72.13M CAD in the quarter ending June 30, 2025, with 8.94% growth. This brings the company's revenue in the last twelve months to 274.92M, down -4.24% year-over-year. In the fiscal year ending March 31, 2025, Canopy Growth had annual revenue of 269.00M, down -9.47%.
Revenue (ttm)
274.92M CAD
Revenue Growth
-4.24%
P/S Ratio
2.09
Revenue / Employee
286,372 CAD
Employees
960
Market Cap
421.71M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CGC News
- 3 days ago - Best Canadian Cannabis Stocks to Watch for Growth and Opportunity - MarijuanaStocks
- 3 days ago - Wall Street Breakfast Podcast: Weed Stocks Light Up - Seeking Alpha
- 4 days ago - Cannabis stocks soar after Trump shares video promoting drug's use for seniors - The Guardian
- 4 days ago - Cannabis stocks surge after Trump posts video touting Medicare coverage for CBD - New York Post
- 4 days ago - President Trump Lights Up Cannabis Stocks With Pro-CBD Truth Social Post - Benzinga
- 4 days ago - US cannabis stocks soar 20% after Trump endorses CBD's benefits for seniors - Invezz
- 4 days ago - Cannabis stocks surge after Trump endorses cannabidiol for senior healthcare - Reuters
- 7 days ago - Canopy Growth Corporation Announces Adjournment of Annual General and Special Meeting of Shareholders Due to Lack of Quorum - Business Wire